Quantitative estimation of 67Ga citrate in hypofunctioning thyroid nodules

Area of Science:

• Nuclear Medicine
• Oncology
• Endocrinology

Background:

• Nonfunctioning, cold thyroid nodules require accurate diagnostic methods.
• Gallium-67 citrate (67Ga) is a radiopharmaceutical used in imaging.
• Differentiating benign from malignant thyroid nodules remains a clinical challenge.

Purpose of the Study:

• To investigate the uptake of 67Ga citrate in nonfunctioning, cold thyroid nodules.
• To compare 67Ga citrate activity in benign nodules versus malignant and inflammatory thyroid conditions.

Main Methods:

• Quantitation of 67Ga citrate radioactivity in blood and excised thyroid tissue.
• Study included 11 subjects undergoing surgery for nonfunctioning thyroid nodules.
• Radioactivity measurements were taken approximately 48 hours post-injection.

Main Results:

• Benign, nonfunctioning nodules showed minimal 67Ga concentration (nodular/blood ratio of 1.6).
• Thyroid cancer patients exhibited higher 67Ga activity (mean ratio 4.5/1).
• One patient with Hashimoto's thyroiditis also showed high 67Ga concentration (ratio 5.3/1).

Conclusions:

• 67Ga citrate demonstrates a lower affinity for benign cold thyroid nodules compared to malignant or inflammatory lesions.
• Findings suggest potential utility of 67Ga citrate in distinguishing thyroid pathologies.
• Additional clinical studies are required to validate these observations.